Yale University

Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.

TitleIncidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
Publication TypeJournal Article
Year of Publication2009
AuthorsBedimo, Roger J., Kathleen A. McGinnis, Melinda Dunlap, Maria C. Rodriguez-Barradas, and Amy C. Justice
JournalJournal of acquired immune deficiency syndromes (1999)
Volume52
Issue2
Pagination203-8
Date Published2009 Oct 1
ISSN1944-7884
KeywordsAdult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Case-Control Studies, CD4 Lymphocyte Count, Cohort Studies, HIV Infections, Humans, Incidence, Male, Middle Aged, Neoplasms
AbstractThe incidence of non-AIDS-defining malignancies (non-ADMs) is reported as unchanged or increasing in the highly active antiretroviral therapy era. Whether incidence of non-ADM is significantly higher in HIV-infected than in HIV-uninfected patients remains unclear.
DOI10.1353/hpu.2012.0006
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links